Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton’s Tyrosine Kinase-Reference-Cited by-同舟云学术

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton’s Tyrosine Kinase

Published:2016-05 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chalmers Samantha A.,Doerner Jessica,Bosanac Todd,Khalil Sara,Smith Dustin,Harcken Christian,Dimock Janice,Der Evan,Herlitz Leal,Webb Deborah,Seccareccia Elise,Feng Di,Fine Jay S.,Ramanujam Meera,Klein Elliott,Putterman Chaim

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep26164.pdf

Reference25 articles.

1. Mohan, C. & Putterman, C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nature Reviews:Nephrology. 11, 329–341, doi: 10.1038/nrneph.2015.33 (2015).

2. Bethunaickan, R., Sahu, R. & Davidson, A. Autoimmunity Vol. 900 Methods in Molecular Biology (ed Andras, Perl ) Ch. 10, 207–232 (Humana Press, 2012).

3. Nashi, E., Wang, Y. & Diamond, B. The role of B cells in lupus pathogenesis. The International Journal of Biochemistry & Cell Biology. 42, 543–550, doi: 10.1016/j.biocel.2009.10.011 (2010).

4. Bergtold, A., Gavhane, A., D’Agati, V., Madaio, M. & Clynes, R. FcR-Bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunology. 177, 7287–7295, doi: 10.4049/jimmunol.177.10.7287 (2006).

5. Schiffer, L. et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunology. 180, 1938–1947, doi: 10.4049/jimmunol.180.3.1938 (2008).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus;International Immunopharmacology;2024-12

2. RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease;Clinical Immunology;2024-08

3. Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases;Autoimmunity Reviews;2024-05

4. Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus;Journal of Neuroinflammation;2024-04-10

5. The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses;Journal of Clinical Investigation;2022-01-04